|
The Practical Faces of Translational Research: Dana-Farber Leads the WayPublished by: IDC Published: Aug. 11, 2008 - 6 Pages Table of ContentsTable of Contents In This Perspective SITUATION OVERVIEW Patient Samples: Recognizing Potential Barriers to the Gold Streamlining the Principal Investigator/ Researcher Experience Creating a Robust IT Infrastructure Foundation Essential guidance Learn More Related Research AbstractThis Health Industry Insights Perspective provides insights on the robust translational research system being implemented at the Dana-Farber Cancer Institute. This solution aspires to fully institutionalize access to patient and clinical data, fully protect patient rights and privacy, and enable real-time query capabilities to allow Dana-Farber researchers to both perform cutting-edge translational research and effectively leverage patient sample resources in pursuit of new grant proposals. To achieve these goals, Dana-Farber has architected a robust IT infrastructure built on InforSense and Oracle product solutions, creating a solution that is only limited by the queries for which researchers have Institutional Review Board (IRB) approval to ask. This Perspective provides insights developed from direct discussions with Dr. John Quackenbush at Dana-Farber and Joseph Donahue from InforSense. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||